Results 241 to 250 of about 205,089 (292)
Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samples. [PDF]
Sci RepGassner FJ +17 more
europepmc +1 more source
Optimizing SRS for Brain Metastases: Understanding the Volume-Gradient Index Relationship. [PDF]
J Clin MedPopescu-Bârhală T +3 more
europepmc +1 more source
Hypo-Fractionated Stereotactic Radiosurgery for the Management of Brain Metastases. [PDF]
Cancers (Basel)Pikis S +4 more
europepmc +1 more source
A longitudinal MRI dataset of brain metastases with tumor segmentations, clinical & radiomic data. [PDF]
Sci DataFlouri D +9 more
europepmc +1 more source
Large language models standardize the interpretation of complex oncology guidelines for brain metastases. [PDF]
Commun Med (Lond)Akkus Yildirim B +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Neurologist, 2004
Systemic cancer is the second most common cause of death for adults in the United States. Twenty percent of these patients develop neurologic symptoms sometime during their illness. An apparent increase in the incidence of both systemic cancers and resulting brain metastases are posing an increasing challenge to health care providers.
Kevin J, Klos, Brian Patrick, O'Neill
+10 more sources
Systemic cancer is the second most common cause of death for adults in the United States. Twenty percent of these patients develop neurologic symptoms sometime during their illness. An apparent increase in the incidence of both systemic cancers and resulting brain metastases are posing an increasing challenge to health care providers.
Kevin J, Klos, Brian Patrick, O'Neill
+10 more sources
Neurologic Clinics, 1991
Brain metastases are the most common intracranial tumors and affect 20% to 30% of patients with systemic cancer. Improvements in diagnostic imaging and recent advances in treatment have resulted in extension of survival and decreased morbidity due to neurologic causes.
P, Peretti-Viton +4 more
openaire +4 more sources
Brain metastases are the most common intracranial tumors and affect 20% to 30% of patients with systemic cancer. Improvements in diagnostic imaging and recent advances in treatment have resulted in extension of survival and decreased morbidity due to neurologic causes.
P, Peretti-Viton +4 more
openaire +4 more sources
Current Opinion in Neurology, 2005
Brain metastases occur in 10-30% of cancer patients, and they are associated with a dismal prognosis. Radiation therapy has been the mainstay of treatment for patients without surgically treatable lesions. For patients with good prognostic factors and a single metastasis, surgical resection is recommended.
Andrew D, Norden +2 more
openaire +3 more sources
Brain metastases occur in 10-30% of cancer patients, and they are associated with a dismal prognosis. Radiation therapy has been the mainstay of treatment for patients without surgically treatable lesions. For patients with good prognostic factors and a single metastasis, surgical resection is recommended.
Andrew D, Norden +2 more
openaire +3 more sources